The progress so far has been slow with the number of doses administered far below the initial projections.

A medical syringe is seen with AstraZeneca company logo. Source: Sipa USA Rafael Henrique / SOPA Images/Si
The progress so far has been slow with the number of doses administered far below the initial projections.